Janney Montgomery Scott
VRTX icon

Janney Montgomery Scott’s Vertex Pharmaceuticals VRTX Stock Holding History

Janney Montgomery Scott’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.7M Buy
84,324
+13,971
+20% +$6.51M 0.09% 214
2025
Q4 		$31.9M Sell
70,353
-7,103
-9% -$3.06M 0.07% 257
2025
Q3 		$30.3M Buy
77,456
+5,566
+8% +$2.33M 0.07% 264
2025
Q2 		$32M Buy
71,890
+3,271
+5% +$1.51M 0.08% 241
2025
Q1 		$33.3M Sell
68,619
-23,573
-26% -$11M 0.09% 209
2024
Q4 		$37.1M Sell
92,192
-35,233
-28% -$16.3M 0.1% 193
2024
Q3 		$59.3M Sell
127,425
-2,384
-2% -$1.15M 0.17% 121
2024
Q2 		$60.8M Buy
129,809
+7,553
+6% +$3.28M 0.19% 108
2024
Q1 		$51.1M Sell
122,256
-6,114
-5% -$2.58M 0.15% 134
2023
Q4 		$52.2M Buy
128,370
+7,176
+6% +$2.65M 0.17% 121
2023
Q3 		$42.1M Sell
121,194
-4,819
-4% -$1.69M 0.16% 126
2023
Q2 		$44.3M Buy
126,013
+838
+0.7% +$282K 0.15% 133
2023
Q1 		$39.4M Sell
125,175
-3,409
-3% -$1.02M 0.16% 129
2022
Q4 		$37.1M Buy
128,584
+21,258
+20% +$6.48M 0.14% 144
2022
Q3 		$31.1M Buy
107,326
+12,506
+13% +$3.6M 0.13% 150
2022
Q2 		$26.3M Sell
94,820
-12,091
-11% -$3.24M 0.12% 177
2022
Q1 		$27.9M Buy
106,911
+52,024
+95% +$12.3M 0.12% 176
2021
Q4 		$12.1M Buy
54,887
+2,439
+5% +$474K 0.05% 342
2021
Q3 		$9.51M Buy
52,448
+1,945
+4% +$380K 0.04% 387
2021
Q2 		$10.2M Sell
50,503
-6,160
-11% -$1.29M 0.04% 359
2021
Q1 		$12.2M Buy
56,663
+2,388
+4% +$525K 0.06% 292
2020
Q4 		$12.8M Sell
54,275
-62,173
-53% -$14.3M 0.06% 279
2020
Q3 		$31.7M Buy
116,448
+10,438
+10% +$2.88M 0.18% 131
2020
Q2 		$30.8M Buy
106,010
+14,990
+16% +$4.06M 0.19% 122
2020
Q1 		$21.7M Buy
91,020
+21,183
+30% +$4.86M 0.17% 144
2019
Q4 		$15.3M Buy
69,837
+33,221
+91% +$6.72M 0.1% 219
2019
Q3 		$6.2M Buy
36,616
+1,573
+4% +$278K 0.05% 372
2019
Q2 		$6.43M Sell
35,043
-1,817
-5% -$318K 0.05% 360
2019
Q1 		$6.78M Sell
36,860
-3,019
-8% -$558K 0.06% 335
2018
Q4 		$6.61M Sell
39,879
-3,639
-8% -$631K 0.06% 314
2018
Q3 		$8.39M Buy
43,518
+8,117
+23% +$1.45M 0.07% 291
2018
Q2 		$6.02M Sell
35,401
-1,324
-4% -$205K 0.06% 334
2018
Q1 		$5.99M Buy
36,725
+5,262
+17% +$859K 0.06% 326
2017
Q4 		$4.71M Buy
31,463
+527
+2% +$78K 0.05% 376
2017
Q3 		$4.7M Buy
30,936
+4,086
+15% +$615K 0.05% 354
2017
Q2 		$3.46M Buy
26,850
+1,796
+7% +$216K 0.04% 409
2017
Q1 		$2.74M Buy
25,054
+5,935
+31% +$523K 0.04% 456
2016
Q4 		$1.41M Buy
19,119
+5,508
+40% +$448K 0.02% 632
2016
Q3 		$1.19M Buy
+13,611
New +$1.29M 0.02% 588
2016
Q2 		– Sell
-11,616
Closed -$923K – 1164
2016
Q1 		$923K Buy
11,616
+6,405
+123% +$579K 0.02% 546
2015
Q4 		$656K Buy
5,211
+1,876
+56% +$226K 0.02% 689
2015
Q3 		$347K Buy
3,335
+78
+2% +$10K 0.01% 996
2015
Q2 		$402K Buy
3,257
+812
+33% +$102K 0.01% 1312
2015
Q1 		$288K Buy
2,445
+270
+12% +$32.4K 0.01% 1797
2014
Q4 		$258K Buy
+2,175
New +$245K 0.01% 1794
2014
Q3 		– Sell
-3,827
Closed -$362K – 2326
2014
Q2 		$362K Sell
3,827
-733
-16% -$51.4K 0.01% 1468
2014
Q1 		$322K Buy
4,560
+1,525
+50% +$121K 0.01% 1411
2013
Q4 		$226K Sell
3,035
-332
-10% -$23.1K 0.01% 1633
2013
Q3 		$255K Buy
+3,367
New +$268K 0.01% 1452

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Janney Montgomery Scott's VRTX Position: Q1 2026 in Review

Janney Montgomery Scott increased its Vertex Pharmaceuticals (VRTX) stake by 20% in Q1 2026, buying an estimated $6.51M and bringing the position to 84,324 shares worth $37.7M. The position accounts for 0.09% of the portfolio, ranked #214.

Janney Montgomery Scott first reported a position in VRTX in Q3 2013 and has held it in 49 quarters since. The position peaked at $60.8M in Q2 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Janney Montgomery Scott held 84,324 shares of Vertex Pharmaceuticals worth $37.7M as of Q1 2026.
  • Janney Montgomery Scott bought 13,971 Vertex Pharmaceuticals shares in Q1 2026, an estimated $6.51M.
  • Vertex Pharmaceuticals made up 0.09% of Janney Montgomery Scott's portfolio in Q1 2026, its #214 holding.
  • Janney Montgomery Scott first reported a position in Vertex Pharmaceuticals in Q3 2013 and has held it in 49 quarters since.
  • Janney Montgomery Scott's Vertex Pharmaceuticals position peaked at $60.8M in Q2 2024.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.